Showing results (91-100 of 211) with videos related to
Sort By:
Pageof 22
Blood Cancer Journal|August 6, 2025
Neutrophil-to-Lymphocyte ratio as surrogate for JAK2<sup>V617F</sup> suppression and event-free survival in polycythemia veraTiziano Barbui, Arianna Ghirardi, Victoria Empson, et al.American Journal of Hematology|January 2, 2024
Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosisVittorio Abbonante, Anastasia Iris Karkempetzaki, Catherine Leon, et al.Plos One|June 10, 2016
Tie2 Expressing Monocytes in the Spleen of Patients with Primary MyelofibrosisRita Campanelli, Gabriela Fois, Paolo Catarsi, et al.Clinical and Translational Medicine|April 25, 2025
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid LeukemiaManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.Leukemia Research|December 16, 2014
PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosisClaudia Augello, Umberto Gianelli, Rossella Falcone, et al.Oncotarget|March 17, 2016
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patientsSimona Soverini, Caterina De Benedittis, Katerina Machova Polakova, et al.American Journal of Hematology|November 23, 2013
Pregnancy complications predict thrombotic events in young women with essential thrombocythemiaMaria Luigia Randi, Irene Bertozzi, Elisa Rumi, et al.Therapeutic Advances in Hematology|September 11, 2023
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in ItalyMarianna De Muro, Annelot Julia Janssen, Sergio Amadori, et al.Clinical Lymphoma, Myeloma & Leukemia|September 25, 2024
Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National NetworkMassimo Breccia, Rosalba Cucci, Giovanni Marsili, et al.Blood Cancer Journal|March 7, 2021
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use programAlessandro Rambaldi, Alessandra Iurlo, Alessandro M Vannucchi, et al.Pageof 22